Prize for IBEC in Technology Transfer competition
An IBEC project pitch won third prize in a Technology Transfer Competition at last week’s Onco Emergence Forum.
The project, which is the brainchild of IBEC group leader Pere Roca-Cusachs and proposes the targeting of tumor mechanics to develop new drugs for oncology, specifically with pancreatic cancer in mind, was pitched by IBEC Technology Transfer manager Diana Gonzalez at the meeting on Friday.
Diana, involved in the project from its onset, was one of twelve finalists chosen to present in six-minute pitches to a panel of judges. The project was shortlisted because of its solid focus on an unmet medical, market or patient need, and because it proposed using innovative technology to create a product or service.
An IBEC project pitch won third prize in a Technology Transfer Competition at last week’s Onco Emergence Forum.
Today more than 300 researchers are meeting at CosmoCaixa to debate the latest scientific advances in cutting-edge fields at the yearly conference of the Barcelona Institute of Science and Technology (BIST).
IBEC group leader Javier Ramón presented the state-of-the-art in 3D printing of biomaterials at a workshop organised by CatalunyaBio & HealthTech last week.
Last weekend IBEC participated in Barcelona’s twelfth Festival de la Ciència with a host of activities.
This month saw the kick-off of the RIS3CAT LLAVOR 3D Community, a partnership of Catalan entities – including IBEC – which will develop projects in additive manufacturing and 3D printing.
Yesterday Nanomed Spain-organised ‘Jornada sobre Nanotoxicidad’ (Workshop on Nanotoxicity) welcomed almost 100 attendees from all over Spain.
IBEC group leader and ICREA research professor Xavier Trepat has been elected as a Member of EMBO, the European Molecular Biology Organisation.
Three of IBEC’s women researchers have been successful in BIST’s recent ‘To the Mothers of Science’ call.
Nearly fifty undergraduate and master students attended today’s reSearch4Talent at IBEC, the fourth time we’ve opened our doors to young scholars interested in a career in science.
Biomaterials for Regenerative Therapies PhD student Jesús Ordoño will spend six months at Michigan State University with a Daniel Bravo scholarship.